There isn't a correct answer
The weight loss medications that we prescribe as a part of our weight loss program in University of California-Santa Barbara, California, whether they are GLP-1 medications or non- GLP-1 medications, help people lose weight through different mechanisms, making them suitable for various needs and health profiles
The general framework used by many providers is as follows, though exact schedules may differ based on the patients health needs and local prescribing guidelines: Initiation and Titration Start at a low weekly dose, commonly 2.5 mg once weekly for about 4 weeks
In a recent Cochrane review, it was stated that the chance of live birth with ICSI is between 30% and 41% (223)
Novo Nordisk pointed to several shortfalls in the study, including that the drugs analyzed are approved for diabetes, not obesity
It can also improve metabolic health by lowering blood sugar levels and reducing the risk of diabetes-related complications